Global coagulation tests to assess the value of the presurgical treatment in a patient with congenital factor XI deficiency and inhibitor

Int J Lab Hematol. 2020 Apr;42(2):e68-e70. doi: 10.1111/ijlh.13113. Epub 2019 Nov 6.

Authors

Eugenia Biguzzi¹, Simona M Siboni¹, Marigrazia Clerici¹, Lidia Padovan¹, Erica Scalambrino^{1

2}, Veena Chantarangkul³, Cristina Novembrino¹, Armando Tripodi³

Affiliations

¹ Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
² Department of Pathophysiology and Transplantation, Fondazione Luigi Villa, Università degli Studi di Milano, Milano, Italy.
³ Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione Luigi Villa, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

PMID: 31693301
DOI: 10.1111/ijlh.13113

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies / blood
Antibodies / immunology
Appendectomy
Blood Coagulation Tests / methods*
Codon, Nonsense*
Factor XI / genetics*
Factor XI / immunology
Factor XI Deficiency / blood
Factor XI Deficiency / diagnosis
Factor XI Deficiency / genetics*
Female
Humans
Preoperative Period

Substances

Antibodies
Codon, Nonsense
Factor XI